Healthcare -
Biotechnology - NASDAQ - US
$ 0.023
-0.87 %
$ 914 K
Market Cap
-0.02
P/E
VIRX - TOTAL CURRENT LIABILITIES
Total Current Liabilities VIRX - Viracta Therapeutics, Inc.
38.4 M
LAST VALUE
105.53%
2 YEAR CAGR
27.65%
5 YEAR CAGR
1.23%
10 YEAR CAGR